Crossmark

Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08062-4

Published Online: 2024-04-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Imran http://orcid.org/0000-0002-2069-7410
Taylor, Stephanie J. C.

Robinson, Clare

Moschopoulou, Elisavet

McCrone, Paul

Bourke, Liam

Thaha, Mohamed

Bhui, Kamaldeep

Rosario, Derek

Ridge, Damien

Donovan, Sheila

Korszun, Ania

Little, Paul

Morgan, Adrienne

Quentin, Olivier

Roylance, Rebecca

White, Peter

Chalder, Trudie
License Information

Text and Data Mining valid from 2024-04-02

Version of Record valid from 2024-04-02
More Information

Article History

Received: 12 December 2023

Accepted: 18 March 2024

First Online: 2 April 2024

Declarations

:

: The protocol, patient information sheets, consent forms, and other trial-related documents have been reviewed and approved by the Sponsor Queen Mary University of London and Barts Health NHS Trust) and Research Ethics Committee (REC) South West - Cornwall & Plymouth Research Ethics Committee (REF: 19/SW/0214). In addition, all protocol amendments were also approved by the REC. Written informed consent will be taken prior to participation.

: An informed consent form (ICF) to participate in the trial has been provided as a supplement.

: PDW provides consultancy to a re-insurance company until the end of 2023.All other authors declare that they have no competing interests.

Document is current

Any future updates will be listed below